Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: a randomized controlled trial.
about
Non-invasive Markers of Liver Fibrosis: Adjuncts or Alternatives to Liver Biopsy?Treatment of patients with type 2 diabetes and non-alcoholic fatty liver disease: current approaches and future directionsQuantitative Imaging Biomarkers of NAFLDLipid-lowering agents in the management of nonalcoholic fatty liver diseaseNoninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat Using a New Quantitative Ultrasound TechniqueComparative efficacy of interventions on nonalcoholic fatty liver disease (NAFLD): A PRISMA-compliant systematic review and network meta-analysis.Noninvasive Markers of Fibrosis and Inflammation in Nonalcoholic Fatty Liver Disease.Magnetic resonance elastography is superior to acoustic radiation force impulse for the Diagnosis of fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease: A prospective study.Non-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE.Novel 3D Magnetic Resonance Elastography for the Noninvasive Diagnosis of Advanced Fibrosis in NAFLD: A Prospective Study.Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin StudyComparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non-invasive diagnosis of advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease: a prospective study.Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial)Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study.Nonalcoholic fatty liver disease: updates in noninvasive diagnosis and correlation with cardiovascular disease.Radiologic evaluation of nonalcoholic fatty liver diseaseNon-invasive assessment of hepatic steatosis in patients with NAFLD using controlled attenuation parameter and 1H-MR spectroscopy.In vivo breath-hold (1) H MRS simultaneous estimation of liver proton density fat fraction, and T1 and T2 of water and fat, with a multi-TR, multi-TE sequence.Identifying nonalcoholic fatty liver disease patients with active fibrosis by measuring extracellular matrix remodeling rates in tissue and blood.Commentary: non-alcoholic fatty pancreas -- toward an uncharted territory; authors' replyAssociation between novel MRI-estimated pancreatic fat and liver histology-determined steatosis and fibrosis in non-alcoholic fatty liver disease.Imaging body fat: techniques and cardiometabolic implicationsSerum alanine aminotransferase as a biomarker of treatment response in nonalcoholic steatohepatitis.Metadoxine Versus Placebo for the Treatment of Non-alcoholic Steatohepatitis: A Randomized Controlled Trial.Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease.Polyunsaturated fatty acid metabolites as novel lipidomic biomarkers for noninvasive diagnosis of nonalcoholic steatohepatitis.Cross-sectional and longitudinal evaluation of liver volume and total liver fat burden in adults with nonalcoholic steatohepatitisAccuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver diseaseEffect of weight loss on magnetic resonance imaging estimation of liver fat and volume in patients with nonalcoholic steatohepatitis.Hepatic fat quantification magnetic resonance for monitoring treatment response in pediatric nonalcoholic steatohepatitis.Accuracy of multiecho magnitude-based MRI (M-MRI) for estimation of hepatic proton density fat fraction (PDFF) in children.Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease - MRI accurately quantifies hepatic steatosis in NAFLDCardiovascular risk assessment in the treatment of nonalcoholic steatohepatitis: a secondary analysis of the MOZART trial.The effect of a bile acid sequestrant on glucose metabolism in subjects with type 2 diabetes.Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trialsAssociations between histologic features of nonalcoholic fatty liver disease (NAFLD) and quantitative diffusion-weighted MRI measurements in adults.Intra- and inter-examination repeatability of magnetic resonance spectroscopy, magnitude-based MRI, and complex-based MRI for estimation of hepatic proton density fat fraction in overweight and obese children and adultsAssociation of noninvasive quantitative decline in liver fat content on MRI with histologic response in nonalcoholic steatohepatitis.Insulin Resistance Increases MRI-Estimated Pancreatic Fat in Nonalcoholic Fatty Liver Disease and Normal Controls.Serum microRNAs explain discordance of non-alcoholic fatty liver disease in monozygotic and dizygotic twins: a prospective study.
P2860
Q26744631-ED6F85AF-AC08-4D23-9700-B7207F7752E1Q26751258-3B9B6FAE-DB7B-476D-B9B7-C07C1CA50937Q26768664-BC0A7D19-CF54-4B71-A929-75293943E22CQ27024352-001AF3CF-4C24-42B6-90A8-2469C50A3F3CQ27318751-606EB0A6-90A9-4DF9-8CD0-09F620137730Q30248535-DFAF409D-A32B-4234-AE6D-BB2C48024386Q30355082-865FB986-CB54-4DC9-946D-D5A8AD024627Q30364476-2331FCDD-8354-4510-9572-9C774E54171BQ30366569-E4336B14-7C42-45C6-985E-3A0DE9F2DFDBQ30366572-704AE313-03C1-41CD-AE57-EF3D3D59E8C4Q30368624-604AD58D-FDEE-4375-9EE4-BECA85F60466Q30382172-43151357-B414-4F8E-92DA-F7D25CE768FDQ30413592-1074AF7A-CD0B-4A92-8CEC-9B538382225FQ30418856-8CF443E8-4C16-4FCA-879F-FDB30B2B0361Q30435948-DF489CAA-D84F-4E2F-B0CF-BF65271FCE07Q30436162-50007CB7-9542-4E11-B8C5-488815ADDBE5Q30441653-897CD26F-728F-47CC-AA27-625E59A4B226Q30976946-C545CD47-9E30-4C89-A746-D792F33D8081Q31134971-BB16FDEE-F5BE-474E-B36E-010F7E512625Q34055573-ED19B746-7C7E-49B4-9660-411E89F1B443Q34060362-DC4030D8-5B6F-4F1C-9CD7-10C181D176F1Q34214390-A89F7917-1EB5-452A-9D61-1D508AE425C8Q34225038-070F222B-3776-4976-87E8-6D49820ED4A9Q34466433-B7BCE1FF-84AC-4728-854B-49D36E39147FQ34540703-4366359C-352F-4B59-B09F-E2B0808BBE33Q34757421-B40D1D9F-E98C-4579-BFFA-7D1F37C5FB55Q34945781-0C8998C9-A7E5-45DB-B244-8E27459038CEQ35039525-322C74E2-43DF-461A-8A22-C4F2A73A0E53Q35096971-9BA54EA8-ABE1-4420-A2CD-CBBEB9C595E8Q36037915-F138163C-B7D7-4C87-B3BE-7E53F72E5D70Q36118818-50795F7E-6F03-49F6-913B-CD8A14A95EA3Q36219404-2EC2050C-F5BA-4386-9EF5-19607A2FCD19Q36569181-776F7D03-285D-4106-9C98-C9D4CEF1B726Q36720538-FB70DB76-EA3A-4771-88D4-7DF2A59105DCQ36762917-A940E51B-4999-4BA7-B49B-86F94EBF98B1Q36762937-9AAA9EC9-49AA-46FF-BA1B-EBDB96099A8AQ36762955-989CB8FB-580B-446A-839B-3FAB06C92140Q37173770-57C93BAF-07F5-42C0-8236-1F86A3AB48F5Q37375111-FBE08777-7965-48F9-BCA8-12C0B6AD61F3Q37384502-5F48D73E-D38D-47AA-A6BF-A48DBEF94858
P2860
Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: a randomized controlled trial.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Effect of colesevelam on liver ...... a randomized controlled trial.
@ast
Effect of colesevelam on liver ...... a randomized controlled trial.
@en
type
label
Effect of colesevelam on liver ...... a randomized controlled trial.
@ast
Effect of colesevelam on liver ...... a randomized controlled trial.
@en
prefLabel
Effect of colesevelam on liver ...... a randomized controlled trial.
@ast
Effect of colesevelam on liver ...... a randomized controlled trial.
@en
P2093
P2860
P356
P1433
P1476
Effect of colesevelam on liver ...... a randomized controlled trial.
@en
P2093
Benjamin L Cohen
Christopher Changchien
Heather Patton
Joshua Chen
Michael R Peterson
Rohit Loomba
San Diego Integrated NAFLD Research Consortium (SINC)
Thuy-Anh Le
P2860
P304
P356
10.1002/HEP.25731
P407
P577
2012-07-02T00:00:00Z